Conference Coverage
Conference Coverage
AES: Sparse evidence hints at epilepsy disease modification
Commentary
Good luck convincing patients that generics equal brand-name drugs
Conference Coverage
Have the conversation early: research proxies in Alzheimer’s disease
Conference Coverage
AES: Three studies show generic lamotrigine equals Lamictal
Key clinical point: Results from three separate, randomized trials in epilepsy patients showed that generic lamotrigine performed identically to...
Conference Coverage
Detailed – not global – tests predict Alzheimer’s progression rates
Key clinical point: Detailed neuropsychological tests predicted Alzheimer’s progression rates better than global measures. Major finding: Patients...
Conference Coverage
Functional dependence linked to risk of complications after spine surgery
Functional dependence following elective cervical spine procedures was associated with a significantly increased risk of almost all 30-day...
Conference Coverage
Study characterizes injury risk in cervical myelopathy patients
Compared with age-matched controls, patients with cervical spondylotic myelopathy had a significantly increased incidence of falls, hip fractures...
Conference Coverage
FDA advisory committees support changing codeine contraindications for children
The FDA’s Pulmonary-Allergy Drugs and Drug Safety and Risk Management Advisory Committees voted strongly in favor of amending codeine’s current...
Conference Coverage
PROMIS physical function domain outperforms in cervical spine patients
In elective cervical spine surgery, the PROMIS physical function domain outperformed other commonly used tools to measure patient-reported...
Conference Coverage
AHA: Ezetimibe reduces ischemic stroke risk
Intensive lipid-lowering therapy that incorporates ezetimibe provides enhanced protection against ischemic stroke.
Conference Coverage
AES: Many U.S. epilepsy patients receive suboptimal treatment
Key clinical point: A sample of newly diagnosed U.S.